Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma
- DOI
- 10.1080/14656566.2026.2749651
- Published
- 2026-11-08
- Container
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14656566.2026.2749651,
title = {Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma},
author = {Kannan Sridharan and Giandomenico Roviello and Francesco Massari and Gowri Sivaramakrishnan and Chiara Calandrelli and Matteo Santoni},
year = {2026},
journal = {Expert Opinion on Pharmacotherapy},
doi = {10.1080/14656566.2026.2749651},
url = {https://doi.org/10.1080/14656566.2026.2749651}
}RIS
TY - JOUR TI - Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma AU - Kannan Sridharan AU - Giandomenico Roviello AU - Francesco Massari AU - Gowri Sivaramakrishnan AU - Chiara Calandrelli AU - Matteo Santoni PY - 2026 JO - Expert Opinion on Pharmacotherapy DO - 10.1080/14656566.2026.2749651 UR - https://doi.org/10.1080/14656566.2026.2749651 ER -
APA
Sridharan, K., Roviello, G., Massari, F., Sivaramakrishnan, G., Calandrelli, C., & Santoni, M. (2026). Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma. Expert Opinion on Pharmacotherapy. https://doi.org/10.1080/14656566.2026.2749651
Source records
- crossref · retrieved 2026-11-10T14:43:56.642Z